Pleo Reb (Sanum Kehlbeck GmbH & Co. KG)


Welcome to the PulseAid listing for the Pleo Reb drug offered from Sanum Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Sanum Kehlbeck GmbH & Co. KG
NON-PROPRIETARY NAME: sus scrofa small intestine mucosa lymph follicle
SUBSTANCE NAME: SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1997-03-19
END MARKETING DATE: 0000-00-00


Pleo Reb HUMAN OTC DRUG Details:

Item DescriptionPleo Reb from Sanum Kehlbeck GmbH & Co. KG
LABELER NAME: Sanum Kehlbeck GmbH & Co. KG
DEA SCHEDULE:
ACTIVE STRENGTH: 5([hp_X]/2mL)
START MARKETING DATE: 1997-03-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60681-3006_7b2a6c35-b60b-406c-9714-a040b776dea5
PRODUCT NDC: 60681-3006
APPLICATION NUMBER:

Other SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sanum Kehlbeck GmbH & Co. KGPleo Reb